A White Plains, N.Y., publishing company has launched what it describes as the first international peer-reviewed journal to evaluate drugs using evidence-based methods. The quarterly magazine, Core Evidence, will focus on clinical outcomes to evaluate drugs for an audience of formulary decisionmakers, prescribing advisers and pharmacists, physicians and healthcare administrators, officials said.
The journal will be guided by a 28-member editorial board of clinicians and leaders in evidenced-based medicine, according to officials at Core Medical Publishing.
"Although information on key clinical and economic outcomes is critical to today's healthcare environment, the data often are not available in a form that is useful to decisionmakers," said Paul Chrisp, the journal's editor-in-chief and publisher. The first issue was published in June.